Saudi Arabia’s fourth Riyadh Global Medical Biotechnology Summit (RGMBS) concluded on September 16 with more than 40 agreements, initiatives and announcements valued at over SAR 5 billion ($1.33 billion), as the Kingdom sought to translate its National Biotechnology Strategy into concrete research, investment, manufacturing and talent-development programs.
